Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Tuesday, November 10, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid...
Ogkologos
-
August 12, 2025
0
A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...
Ogkologos
-
August 11, 2025
0
ESMO Recommendations on Cancer Care Reflected in Un ECOSOC Ministerial Declaration...
Ogkologos
-
August 11, 2025
0
FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple...
Ogkologos
-
August 8, 2025
0
EMA Recommends Extension of Therapeutic Indications for Darolutamide
Ogkologos
-
August 7, 2025
0
Savolitinib Plus Osimertinib Show a High Response in EGFR-mutated NSCLC Progressed...
Ogkologos
-
August 6, 2025
0
2025 ESMO Society Award recipients announced
Ogkologos
-
August 5, 2025
0
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ogkologos
-
August 5, 2025
0
A Combination of Avutometinib Plus Defactinib Results in Clinically Meaningful Benefit...
Ogkologos
-
August 5, 2025
0
OS Benefit from TTFields with Gemcitabine/Nab-paclitaxel for Patients with Unresectable Locally...
Ogkologos
-
August 4, 2025
0
1
...
42
43
44
...
440
Page 43 of 440
MOST POPULAR
Neoadjuvant GOLP Prolongs EFS Among Patients with Resectable High-Risk Intrahepatic Cholangiocarcinoma
March 16, 2026
Research with integrity – all the fun of the FAIR
August 8, 2023
Pine Trees or COVID?
September 2, 2020
EMA Recommends Extension of Indications for Tislelizumab
July 24, 2025
Load more
HOT NEWS
A Combination of Talazoparib and Enzalutamide Prolongs OS in Unselected and...
EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab
Program Helps Medically Underserved, Minority Cancer Survivors Be More Active
Boy Asks Mom Fighting Cancer To Take Off Her Turban So...
Ελληνικά
English (UK)
